Dal Poggetto John
Transaction: 07/09/2026
BUY
Change
+7,500
Price
Not reported
Filing
07/09/2026
Type
BUY
Sonoma Pharmaceuticals, Inc.
SNOA • Drug Manufacturers - Specialty & Generic
$1.32
▲ +0.00 (+0.38%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$5.10M
Growth
-16.3%
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.27Healthy liquidity · 2.5Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$1.33
Change0.38%
Shares Out3.85M
Market Cap$5.10M
Enterprise Value$496.95K
52W Range0.85 - 6.92
Beta1.30
P/E-2.25
P/S0.23
P/B0.77
P/FCF-3.16
EV/Sales0.02
Price$1.33
Change0.38%
Shares Out3.85M
Market Cap$5.10M
Enterprise Value$496.95K
52W Range0.85 - 6.92
Beta1.30
P/E-2.25
P/S0.23
P/B0.77
P/FCF-3.16
EV/Sales0.02
EV/EBITDA-0.22
EV/FCF-0.31
Earnings Yield-44.43%
FCF Yield-31.63%
Dividend Yield0.00%
Gross Margin37.97%
Oper. Margin-12.60%
Profit Margin-16.26%
Debt/Eq0.27
Current Ratio2.50
Quick Ratio1.75
Revenue 5Y-16.30%
Volume36.21K
Avg Volume222.22K
EPS Surprise-0.06
Investment DNA
How strong this company looks for long-term investors
42
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
94/100
Why this score▼
Manageable debt level · 0.27Healthy liquidity · 2.5Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 2 analyst votes · 2026-09-05
75/100
Bullish
Bullish
1
Hold
1
Bearish
0
Insider Transactions
Recent executive and insider activity
DVONCH JEROME J
Transaction: 07/09/2026
BUY
Change
+10,000
Price
Not reported
Filing
07/09/2026
Type
BUY
Jacoby Vanessa
Transaction: 07/09/2026
BUY
Change
+10,000
Price
$1.26
Filing
07/09/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Dal Poggetto John | BUY | +7,500 | Not reported | 07/09/2026 | 07/09/2026 |
| DVONCH JEROME J | BUY | +10,000 | Not reported | 07/09/2026 | 07/09/2026 |
| Jacoby Vanessa | BUY | +10,000 | $1.26 | 07/09/2026 | 07/09/2026 |
| MCLAUGHLIN JOHN | BUY | +10,000 | $1.26 | 07/09/2026 | 07/09/2026 |
| Trombly Amy Moss | BUY | +10,000 | Not reported | 07/09/2026 | 07/09/2026 |
| Weigerstorfer Philippe | BUY | +10,000 | $1.26 | 07/09/2026 | 07/09/2026 |
| Jacoby Vanessa | OTHER | +10,000 | $10000.00 | 01/28/2027 | 02/09/2026 |
| Birnbaum Jay E | BUY | +10,000 | $3.68 | 01/02/2026 | 01/02/2026 |
| Dal Poggetto John | BUY | +5,000 | Not reported | 01/02/2026 | 01/02/2026 |
| DVONCH JEROME J | BUY | +5,000 | Not reported | 01/02/2026 | 01/02/2026 |
| MCLAUGHLIN JOHN | BUY | +10,000 | $3.68 | 01/02/2026 | 01/02/2026 |
| Trombly Amy Moss | BUY | +10,000 | Not reported | 01/02/2026 | 01/02/2026 |
| Weigerstorfer Philippe | BUY | +10,000 | $3.68 | 01/02/2026 | 01/02/2026 |
| Trombly Amy Moss | BUY | +13,500 | Not reported | 06/19/2025 | 06/20/2025 |
| DVONCH JEROME J | BUY | +13,500 | Not reported | 06/19/2025 | 06/20/2025 |
| Dal Poggetto John | BUY | +10,000 | Not reported | 06/19/2025 | 06/20/2025 |
| Thornton Bruce | BUY | +13,500 | Not reported | 06/19/2025 | 06/20/2025 |
| Dal Poggetto John | BUY | +7,500 | Not reported | 01/02/2025 | 01/03/2025 |
| DVONCH JEROME J | BUY | +10,000 | Not reported | 01/02/2025 | 01/03/2025 |
| Weigerstorfer Philippe | BUY | +7,500 | $2.68 | 01/02/2025 | 01/03/2025 |